Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Taxes |
|
| Schedule of tax expense |
| | | | | | | | | | (Amounts in thousands) | | December 31, 2025 | | December 31, 2024 | | December 31, 2023 | Current income tax | | | | | | | | | | Federal | | $ | (1,093) | | $ | (3,091) | | $ | 710 | State | | | 832 | | | (310) | | | 620 | Foreign | | | (500) | | | 1,260 | | | 2,633 | Deferred income tax | | | | | | | | | | Federal | | | (50,160) | | | (37,131) | | | (6,394) | State | | | (11,464) | | | (7,390) | | | (2,616) | Foreign | | | 2,057 | | | (6,717) | | | (319) | Valuation allowance | | | 116,825 | | | 6,487 | | | (3,161) | Income tax expense (benefit) | | $ | 56,497 | | $ | (46,892) | | $ | (8,527) |
|
| Schedule of effective income tax rate reconciliation |
| | | | | | | | | | December 31, 2025 | (Amounts in thousands) | | Amount | | Percent | | Statutory rate | | $ | (52,892) | | | 21.0 | % | State income taxes - net of federal benefit (1) | | | 10,081 | | | (4.0) | % | Foreign Tax Effects (2) | | | | | | | | Canada | | | 1,790 | | | (0.7) | % | Bahamas | | | (682) | | | 0.3 | % | United Kingdom | | | — | | | — | % | Effect of cross-border tax laws | | | | | | | | Effect of GILTI inclusion | | | 914 | | | (0.4) | % | Tax Credits | | | | | | | | Research and development tax credits | | | 103 | | | — | % | Change in valuation allowance | | | 95,257 | | | (37.8) | % | Nontaxable or nondeductible items | | | | | | | | Other | | | (200) | | | 0.1 | % | Changes in unrecognized tax benefits | | | 36 | | | — | % | Other | | | | | | | | Prior period true-up | | | 2,225 | | | (0.9) | % | Other | | | (135) | | | — | % | Income tax expense | | $ | 56,497 | | | (22.4) | % |
| (1) | State taxes in Florida, New York City, and New York made up the majority (greater than 50%) of the tax effect in this category in the current year. |
| (2) | The Company has determined that there are no reconciling items for all foreign jurisdictions that meet the 5% threshold. As a result, no further disaggregation of the foreign jurisdictions reconciling items has been presented. |
| | | | | | | (Amounts in thousands) | | December 31, 2024 | | December 31, 2023 | Statutory rate | | $ | (32,008) | | $ | (5,721) | State income taxes - net of federal benefit | | | (7,644) | | | (2,918) | Change in effective state tax rate | | | 5 | | | 940 | Revocation of S-corporation status | | | — | | | 4,799 | Earnout | | | — | | | (4,345) | Foreign rate differential | | | (13,155) | | | (5,501) | Change in valuation allowances | | | 6,487 | | | (3,161) | Effect of foreign tax credits | | | — | | | (443) | Effect of uncertain tax positions | | | (4,279) | | | 459 | Prior year true-ups | | | (254) | | | 297 | Effect of GILTI Inclusion | | | — | | | 8,193 | Effect of deferred true-ups | | | 1,368 | | | 254 | Research and development tax credits | | | (1,712) | | | (1,062) | Other | | | 4,300 | | | (318) | Income tax expense (benefit) | | $ | (46,892) | | $ | (8,527) |
| | | | | | (Amounts in thousands) | | December 31, 2024 | | December 31, 2023 | | Statutory rate | | 21.0 | % | 21.0 | % | State income taxes - net of federal benefit | | 5.1 | % | 10.7 | % | Change in effective state tax rate | | — | % | (3.5) | % | Revocation of S-corporation status | | — | % | (17.6) | % | Earnout | | — | % | 15.9 | % | Foreign rate differential | | 8.6 | % | 20.2 | % | Change in valuation allowances | | (4.3) | % | 11.6 | % | Effect of foreign tax credits | | — | % | 1.6 | % | Effect of uncertain tax positions | | 2.8 | % | (1.7) | % | Prior year true-ups | | 0.2 | % | (1.1) | % | Effect of GILTI inclusion | | — | % | (30.1) | % | Effect of deferred true-ups | | (0.9) | % | (0.9) | % | Research and development tax credits | | 1.1 | % | 3.9 | % | Other | | (2.8) | % | 1.3 | % | Total | | 30.8 | % | 31.3 | % |
|
| Schedule of income taxes paid net of refunds |
| | | (Amounts in thousands) | December 31, 2025 | Domestic | | | New York City | $ | 392 | Oklahoma | | 202 | New York | | 101 | Missouri | | 87 | Tennessee | | 76 | Other states | | 49 | Foreign | | | Canada | | 256 | Total cash paid for income taxes, net of refunds | $ | 1,163 |
|
| Schedule of deferred income tax assets and deferred tax liabilities |
| | | | | | | (Amounts in thousands) | | December 31, 2025 | | December 31, 2024 | Deferred tax assets: | | | | | | | Net operating loss carryforwards | | $ | 90,476 | | $ | 55,250 | Deferred compensation | | | 2,232 | | | 2,940 | Lease liability | | | 2,474 | | | 2,541 | Real estate transaction | | | 10,687 | | | 10,111 | Capitalized research and development expenditures | | | 9,048 | | | 15,295 | Interest expense limitation | | | 19,260 | | | 10,674 | Loss reserves | | | 2,363 | | | 3,871 | Research and development tax credits | | | 1,886 | | | 2,853 | Legal settlements | | | 23,656 | | | — | Other | | | 2,288 | | | 1,938 | Total deferred tax assets | | | 164,370 | | | 105,473 | | | | | | | | Valuation allowance | | | (143,267) | | | (25,209) | | | | | | | | Deferred tax liabilities: | | | | | | | Property and equipment | | | (11,397) | | | (11,741) | Intangible assets in excess of tax basis | | | (679) | | | (627) | Passthrough income / joint ventures | | | (1,450) | | | (4,929) | ROU asset | | | (2,493) | | | (2,551) | Deminimis contracts | | | (738) | | | (2,385) | Other | | | (7,375) | | | (3,792) | Total deferred tax liabilities | | | (24,132) | | | (26,025) | | | | | | | | Net deferred tax assets | | $ | (3,029) | | $ | 54,239 |
|
| Schedule of uncertain tax positions |
| | | | | | | (Amounts in thousands) | | December 31, 2025 | | December 31, 2024 | Balance at beginning of period | | $ | 243 | | $ | 4,522 | Additions to current year tax positions | | | — | | | — | Additions to interest and penalties on prior year tax positions taken | | | 36 | | | 32 | Reductions to prior year tax positions | | | — | | | (3,412) | Reductions to interest and penalties on prior year tax positions taken | | | — | | | (899) | Balance at end of period | | $ | 279 | | $ | 243 |
|